Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer
Clinical trial NCT05065411 · TERMINATED
Trial details
- NCT number
- NCT05065411
- Sponsor
- Veru Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-11
- Primary completion
- 2023-10-19
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.